baber/WOPTO huggingface dataset:
Patent IL-76322-A0 (IL)
Title: N-(1-alkyl or arylmethyl)-4(1h)-pyridinylidine)-alkanamines and addition salts thereof,their preparation and antimicrobial compositions containing them
IPC: A61K31/4425
Filed: 1985-09-06
Abstract: N-[1-(alkyl or arylmethyl)-4(1H)-pyridinylidine]alkanamine and pharmaceutically acceptable acid addition salts thereof, for example, N-(1-octyl-4(1H)-pyridinylidinel-octan- amine monohydrochloride salt, which are useful as antimicrobial agents, especially on living tissues and non-living surfaces and most especially against pathogenic dental microbes, and a process for preparation, methods of use and compositions thereof are disclosed.
Patent IL-94701-A0 (IL)
Title: Crystalline cephem acid addition salts and processes for their preparation
IPC: A61K31/546
Filed: 1990-06-11
Abstract: Crystalline cephem acid addition salts of the general formula II <IMAGE> pharmaceutical preparations active against bacterial infections and which contain such cephem derivatives, process for preparing the cephem derivatives and the pharmaceutical preparations, and use of the cephem derivatives for controlling bacterial infections.
Patent IL-99928-A0 (IL)
Title: Biological control of pests
IPC: C12R1/07
Filed: 1991-11-01
Abstract: PCT No. PCT/GB91/01957 Sec. 371 Date Apr. 15, 1993 Sec. 102(e) Date Apr. 15, 1993 PCT Filed Nov. 7, 1991 PCT Pub. No. WO92/08354 PCT Pub. Date May 29, 1992.The invention relates to the biological control of Dipteran pests other than the mosquito, which comprises the use of Bacillus thuringiensis isolate HD 541 (NCIMB 40373) or HD 571 (NCIMB 40374), or a mutant, recombinant or derivative thereof, or insecticidal material derived therefrom.
Patent FI-20021863-A0 (FI)
Inventor: KIM SUNG-HOON
IPC: H04B7/005
Filed: 2002-10-18
Abstract: The method includes the steps of receiving information regarding the quality of the channel from the multiplicity of user equipment (UE) and improving or diminishing the power of emission of the node B on the base of the poor quality channel information received among the quality information received from the multiplicity of user equipment.  The method is for controlling the emission power of multiple user equipment for a multimedia multi-broadcast service in a mobile communication system having a node B and the multiplicity of user equipment able to communicate with this node B, this node able to broadcast multimedia data towards specific user equipment among the multiplicity of user equipment.
Patent FI-20022073-A0 (FI)
IPC: D21C11/12
Filed: 2002-11-20
Abstract: The present invention relates to recovery of ammonia from ammonia-containing material flows in a chemical pulp mill for decreasing nitrogen oxide emissions of the mill. When practicing this method, the ammonia-containing material flow originating from steam stripping of condensates is adjusted by means of alkali to a value of over 10 and is made into contact with steam for separating ammonia from the material flow. The recovered ammonia is used as a chemical in a combustion device in the chemical pulp mill in a way known per se to reduce detrimental nitrogen oxide emissions of the mill. <IMAGE>
Patent FI-20031559-A0 (FI)
Inventor: JAHKONEN PEKKA
IPC: B66B11/04
Filed: 2003-10-24
Abstract: A method and an apparatus for determining the position of the rotor of a synchronous motor (1) used as an elevator motor, in which method an alternating current of a certain frequency is fed into the stator of the motor and the vibration of the machine is measured as a function of the rotor angle, and the position of the rotor (11) is determined by utilizing the said vibration.
Patent FI-20040285-A0 (FI)
Inventor: SEPPAENEN KARI
IPC: H04L12/56
Filed: 2004-02-24
Abstract: In the present invention, packets are routed in a distributed and dynamic manner via an internal packet-switched telecommunication network comprising edge devices. A data packet is received from an external telecommunication network to a source edge device (10), wherein there is determined the address of the next-hop corresponding to the destination address prefix of the received data packet (11). The address and network interface of the target edge device corresponding to the determined next hop are determined (12) and there is generated a transmission packet addressed to the determined target edge device (13), the transmission packet comprising the received data packet and the determined address of the next hop and the determined network interface of the target edge device. The generated transmission packet is transmitted from the source edge device to the target edge device via one or more internal telecommunication networks at the data link layer level (17). The data packet is sent further via the network interface of the target edge device based on the next-hop address in question (16). <IMAGE>
Patent IL-100830-A0 (IL)
Title: Method of treating leather with polymeric retan fatliquor
IPC: C14C3/22
Filed: 1992-01-31
Abstract: A method for treating leather with a low fogging, substantive, retan fatliquor containing a solution or a dispersion of a selected amphiphilic copolymer, substantially free from organic solvents, formed from a predominant amount of at least one hydrophobic monomer and a minor amount of at least one copolymerizable hydrophilic monomer. The method produces leather having desirable strength and softness qualities and particularly reduced fogging characteristics. The treated leather is particularly suitable for use in vehicle upholstery.
Patent IL-112088-A0 (IL)
Title: Novel stem cell factor formulations and methods
IPC: A61K31/715
Filed: 1994-12-20
Abstract: The invention relates to a novel formulation of stem cell factor. The formulation contains histidine, glutamic acid, sucrose and mannitol. The formulation has a pH between 5.0 and 6.0 and has been lyophilized.
Patent IL-126557-A0 (IL)
Title: Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
IPC: C07D215/48
Filed: 1997-05-20
Abstract: The subject invention concerns novel compounds of the general formula (i)   <IMAGE>   that are useful in treating disease states, such as those states associated with proteins that mediate cellular activity. The compounds of the subject invention can be used, for example, to inhibit tumor necrosis factor and/or phosphodiesterase IV, The subject invention also concerns methods for treating disease states using the compounds of the invention.
Patent IL-127957-A0 (IL)
Title: Gambling game system and method for remotely-located players
IPC: A63F3/00
Filed: 1999-01-07
Abstract: In some embodiments of the present invention a gambling game system is disclosed, comprising a central station including a plurality of betting-type game devices, and an electronic camera for each game device A plurality of player stations remotely located with respect to the central stations, each one including a monitor for displaying a selected game device at the central station, and input means for selecting a game device and for placing a bet by a player at the player's station relating to an action involving an element of change to occur at the selected game device
Patent IL-137876-A0 (IL)
Title: Bicyclic pyrrole derivatives as mcp-1 inhibitors
IPC: A61P9/00
Filed: 1999-02-02
Abstract: A pharmaceutical composition comprising a compound of formula (I):or a pharmaceutically acceptable salt, ester or amide thereof, which is an inhibitor of monocyte chemoattractant protein-1 and wherein A and B together form an optionally substituted 5-member aromatic ring which includes at least one heteroatom; R1 is an optionally substituted aryl or heteroaryl ring; R2 is selected from a range of organic groups including carboxy, and R3 is hydrogen, or a range of organic groups; in combination with a pharmaceutically acceptable carrier. Certain compounds of formula (I) are novel and these form a further aspect of the invention.
Patent IL-145712-A0 (IL)
Title: Ether compounds, compositions, and uses thereof
IPC: A61K31/6615
Filed: 2000-03-31
Abstract: The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Patent IL-153684-A0 (IL)
Title: Electronic circuit for converting a signal and amplifier incorporating same
Inventor: LAMBRUSCHI RENE
IPC: H03F3/217
Filed: 2001-07-26
Abstract: An electronic circuit for the conversion of an input electric signal (In) comprises:at least two transistors (4, 5) of complementary polarities and mounted with a common drain,control elements (2) for the transistors (4, 5) adapted to generate a single control signal (13) for the grids of the transistors (4, 5), an output line (14) connected to the sources of the transistors. The invention also relates to a power amplifier with cutting out of the voltage control, including this circuit.
Patent IL-177198-A0 (IL)
Title: Method and apparatus for dynamic backhaul resource management in a wireless communication system
IPC: H04W72/04
Filed: 2006-08-01
Abstract: Various embodiments are described to address the need to lower backhaul costs for EGPRS operators while maintaining the low and constant delay characteristics they require. 20 msec TRAU frames ( 221 - 226 ) are still used for backhaul to maintain the low and constant delay. However, to eliminate the restriction of mapping TRAU timeslots to air timeslots ( 211 - 218 ) one-to-one, the TRAU slots are collectively treated as a one large 20 msec TRAU frame for a group of air timeslots. The data for the air timeslots can be packed efficiently into this giant TRAU frame, ignoring backhaul timeslot boundaries. In this way, the appropriate amount of backhaul for the carrier can be allocated and the data for the air interface timeslots more efficiently packed into the backhaul.
Patent IL-178628-A0 (IL)
Title: Polymer blend of non-compatible polymers
Filed: 2006-10-15
Abstract: The invention relates to a polymer blend composed of a polypropylene and/or of a polypropylene copolymer and of another polymer which is incompatible with the polypropylene and/or with the polypropylene copolymer. The polymer is obtained via mixing of the melts of the two polymers with high energy input. After cooling, and also after remelting and further processing via, for example, injection molding, it shows no separation of the phases. The invention further relates to a polymer blend which can be obtained by the inventive process, and also to a molding composed of the polymer blend.
Patent IL-226649-A0 (IL)
Title: Inhaler
IPC: A61M15/00
Filed: 2013-05-30
Abstract: An inhaler (1) comprising a housing (2) to receive a blister (6a) having a puncturable lid (6c) and containing a dose of medicament for inhalation by a user is disclosed. It comprises a mouthpiece (5) through which a dose of medicament is inhaled by a user, a blister piercing member (7) comprising at least two discrete piercing heads (9) operable to pierce a corresponding number of holes in said blister, an actuator (3) comprising an arm pivotally mounted to the housing at one end, and an opening formed in the vicinity of each piercing head. At least one of said openings forms an airflow inlet into said blister and, at least one other of the openings forming an airflow outlet from said blister. The mouthpiece includes a primary chamber (31) having an outside air inlet (34) in communication, via the primary chamber, with the or each airflow inlet opening and, a secondary chamber (32) in communication with the or each airflow outlet opening. When a user inhales through the mouthpiece, air is drawn through the or each airflow inlet opening into the blister via the outside air inlet and the primary chamber to entrain the dose in the airflow, said entrained dose passing through the or each airflow outlet opening into the secondary chamber of the mouthpiece from where it is carried into the user's airway.
Patent RO-134370-A0 (RO)
Title: Method for activation of a tuff-based material to be used as material for filtering iron and manganese from water
Inventor: AŞCHILEAN IOAN
IPC: C02F1/42
Filed: 2019-04-22
Abstract: The invention relates to a method for activation of a tuff-based material to be used as material for filtering iron and manganese from water, as an efficient low-cost alternative in the field of filtering and purifying ground- and surface-water. According to the invention, the method consists in taking a tuff sample, washed, dried, ground up to a granulation of 2...3 mm and subsequently thermally activated at a temperature ranging between 180...220°C for 3...5 hours, the filter formed with said tuff-based material enabling the simultaneous retention of iron and manganese ions from water, with an efficiency ranging between 80...100%.
Patent RO-135863-A0 (RO)
Title: Process for making and using 3d-printed preview pieces for occlusion templates
Inventor: CIOCAN LUCIAN TOMA
IPC: G06T17/00
Filed: 2022-02-08
Abstract: The invention relates to a process for making and using 3D-printed preview pieces for occlusion templates, meant to be used in dentistry. According to the invention, the process consists of the following steps: selecting an upper dental arch whose dimension is digitalized with a calibrated maximum thickness of 2 mm, digitally designing a set of 3-5 preview pieces of various dimensions, while maintaining the ideal dental proportions for said dental arch, 3D-printing the set of pieces, moulding the occlusion border of the upper template to the shape and level of the desired arch, using wax, establishing the correct dimensions of upper frontal teeth for the clinical case to be treated, selecting one of the preview pieces and fixation on the vestibular surface of the upper template, verifying the support of the upper lip and phonetics, registering occlusal intermaxillary relations and transmitting them to the technician.
Patent RO-137278-A0 (RO)
Title: Portulaca oleracea/magnetite phyto-carrier system with targeted action
Inventor: SEGNEANU ADINA- ELENA
IPC: G01N24/08
Filed: 2022-09-26
Abstract: The invention relates to a phyto-carrier system consisting of a medicinal plant from the spontaneous flora, Portulaca oleracea, in a dry state and magnetite nanoparticles, the system being meant to be used in medicine to transport the plant into the body to the affected tissue or organ in a targeted manner, using a magnetic component. According to the invention, the system consists of 80% mass percentage plant and 20% mass percentage magnetite nanoparticles, introduced and crushed for 20...30 minutes in a ball mill made of an inert material, while the plant is charged with magnetite nanoparticles, after which the mixture is introduced in predetermined amounts into biodegradable polymer capsules that can be easily swallowed by people with ailments.
Patent AP-2000001879-A0 (AP)
Title: Salts of paroxetine.
Inventor: CROWE DAVID
Filed: 1999-02-05
Abstract: A salt of paroxetine with an acid selected from the group consisting of sulphuric, tartaric, oxalic, fumaric, propionic, formic, glutamic, succinic, benzoic, citric, nitric, phosphoric, 4-methylbenzenesulphonic, hypophosphorous, lactic, and mandelic acids and glycine, is useful in the treatment and prophylaxis of certain cns disorders.
Patent AP-2002002621-A0 (AP)
Title: Pharmaceutical compositions of glycogen phosphorylase inhibitors
Inventor: HOOVER DENIS JAY
IPC: A61K9/14
Filed: 2001-03-16
Abstract: Pharmaceutical compositions comprise a glycogen phosphorylase inhibitor and at least one concentration-enhancing polymer. The composition may be a simple physical mixture of glycogen phosphorylase inhibitor and concentration-enhancing polymer or a dispersion of glycogen phosphorylase inhibitor and polymer.
Patent IE-900012-A1 (IE)
Title: multi-dose syringe
Inventor: HJERTMAN BIRGER TURE YNGVAR
IPC: A61M5/32
Filed: 1990-01-03
Abstract: A prefilled syringe comprising a phial (11) containing a measured quantity of an injectable product, a plunger (5) to expel the product out of the phial through a needle, and a two-part housing (1,2) for the phial and plunger in which the two parts are connected by interengaging screw threads (3,4). A stop surface on one housing part cooperates with a corresponding surface (7) on the plunger to limit displacement of the plunger (5) into the phial (11), and the position relative to the phial of the stop surface can be varied by rotating the two housing parts (1,2) relative to one another. A graduated dosing ring (19) is mounted coaxial with, adjacent to, and rotatable relative to both housing parts (1,2).
Patent LU-73335-A1 (LU)
IPC: A47C1/031
Filed: 1975-09-05
Abstract: An adjustable chair the structure of which features a supporting structure, a thigh supporting frame which is rigidly connected to the supporting structure, a buttocks support which is pivotally connected to the supporting structure, a back frame rigidly affixed to the buttocks support at an angle thereto, the buttocks support being adjustably connected to the thigh supporting frame by laterally spaced pivotal connections for adjusting the inclination of the buttocks support relative to the thigh supporting frame, a unitary, taut resilient covering which is disposed upon and interconnects with both the thigh supporting frame and buttocks support, said covering having cut out portions in the area of the buttocks support adjacent each pivotal connection and extending from the back frame to a portion of the thigh support frame adjacent each pivotal connection whereby when said buttocks support adjacent each pivotal connection and extending from the back frame to a portion of the thigh supporting frame adjacent each pivotal connection is in its lowermost position said resilient covering is less taut than when said buttocks support is in its uppermost position.
Patent LU-83244-A1 (LU)
Inventor: HERNESTAM SVEN ARNE HARRY
IPC: C07D265/30
Filed: 1981-03-20
Abstract: Novel morpholino compounds having the general formula   <IMAGE> I wherein R1 is a straight or branched alkyl group containing 8 to 16 carbon atoms at the 2- or 3-position of the morpholino ring, and R2 is a straight or branched alkyl group containing 2 to 10 carbon atoms, substituted with a hydroxy group except in the alpha-position, the sum of the carbon atoms in the groups R1 and R2 being at least 10 and preferably 10 to 20; and pharmaceutically acceptable salts thereof. Compositions for the treatment of the oral cavity and especially the tooth surfaces containing the novel compound or a salt thereof, preferably from 0.1 to 5% by weight thereof. Use of the compounds to inhibit the formation of dental plaque or remove plaque already formed by application of the compound in an aqueous solution or a composition to the surfaces of the oral cavity, especially the surfaces of the teeth. Processes for the preparation of the compounds.
Patent MA-20455-A1 (MA)
IPC: H05K5/03
Filed: 1985-06-14
Abstract: PCT No. PCT/SE85/00219 Sec. 371 Date Jan. 23, 1986 Sec. 102(e) Date Jan. 23, 1986 PCT Filed May 24, 1985 PCT Pub. No. WO86/00491 PCT Pub. Date Jan. 16, 1986.A sealing device in metal cabinets, which are used to screen off electromagnetic fields, for compressing metallic gaskets along the edges of its door. The device includes an elongate element (3,5,18) the length of which conforms with that of the door (1,2) and which is pivotable about an axis (7) parallel to the pivoting axis of the door. At its pivoting axis (7) the element is provided with a first elongate contact surface (10) which presses against the gasket (12) with a leverage effect when the element is turned to one end position. A second elongate contact surface (8) disposed on the element simultaneously engages against an abutment (9,16) to prevent the door from warping due to the pressure applied against the gasket.
Patent MA-26867-A1 (MA)
Title: Ether-dicarboxylates de calcium, procedes pour leur preparation et traitement de maladies vasculaires et du diabete avec ces composés
Inventor: HOWARD YOSHIHISA ANDO
IPC: A61P9/14
Filed: 2002-07-22
Abstract: DEPOSANT Société dite: WARNER-LAMBERTCOMPANY REVENDICATION DE PRIORITES US 25 Janvier 2000 60/177,823 "Ether-dicarboxylates de calcium, procédés pour leur préparation et traitement de maladies vasculaires et du diabète avec ces composés" Les produits de solvatation avec des alcools et l'eau du sel monocalcique d'acide 6-(5-carboxy-5-méthyi-hexyloxy)-2,2-diméthyl-hexanoïque sont cristallins et répondent à la formule (I),  dans laquelle R1 représente H ou un groupe alkyle inférieur, et x est un nombre de 0 à 10, et sont utiles pour le traitement de la dyslipidémie.
Patent MA-26879-A1 (MA)
Title: Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation.
Inventor: ACHARD DANIEL
IPC: A61K31/4178
Filed: 2002-08-28
Abstract: COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE 3-AMINO-AZETIDINE, LES NOUVEAUX DERIVES ET LEUR PREPARATION AVENTIS PHARMA S.A. La présente invention concerne des compositions pharmaceutiques contenant comme ingrédient actif un composé de formule : dans laquelle R, représente un radical -NHCOR4 ou -N(R5)-Y-R6, Y est CO ou SO2, R4 représente un radical -alk-SO2R11, -alk-SO2-CH=CH-R11, Het substitué par SO2R11 ou phényle substitué par SO2-R11 ou -alk-SO2-R11, R5 représente un atome d'hydrogène ou un radical alkyle, R6 représente un radical phénylalkyle, Het ou Ar, les nouveaux dérivés de formule (I) et leur préparation.
Patent MA-27780-A1 (MA)
Title: Melanges fongicides pour lutter contre des pathogenes du riz
Inventor: TORMO I BLASCO JORDI
IPC: A01N43/90
Filed: 2005-11-22
Abstract: Mélanges fongicides destinés à lutter contre les agents pathogènes du riz, contenant comme composants actifs 1) de l'azoxystrobine de formule I,  et  2) le composé de formule II, en une quantité synergiquement active, procédés pour lutter contre les champignons nuisibles par des 15 mélanges du composé I avec le composé II, utilisation des composés I et II pour la préparation de ces mélanges ainsi qu'agents contenant ces mélanges.
Patent MA-42883-A1 (MA)
Title: Raccord muni d'un dispositif de retenue à languettes et d'orifices d'observation
Inventor: SITH AHMAD
IPC: F16L23/18
Filed: 2017-05-15
Abstract: La présente invention concerne un raccord de tuyau conçu pour un tuyau d'extrémité lisse et constitué de parties logements définissant des réceptacles pour recevoir des éléments de tuyau. Les réceptacles sont coaxiaux avec des axes respectifs orientés de manière angulaire les uns par rapport aux autres. Chaque réceptacle présente un canal qui fait face à un axe respectif avec des planchers à différents rayons de courbure. Des dispositifs de retenue sont reçus dans les canaux. Les dispositifs de retenue co
Patent MA-44031-A1 (MA)
Title: Plantes produisant des fruits sans graines
Inventor: SIRIZZOTTI ALBERTO
IPC: C12N15/82
Filed: 2017-05-19
Abstract: La présente invention concerne des plantes produisant des fruits sans graines. La présente invention concerne également des procédés de production desdites plantes et l'utilisation d'acides nucléiques codant pour des protéines de type cycline-sds pour la production de fruits sans grain